Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications

<p><strong>Aims</strong> Myocardial fibrosis as detected by late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is a powerful prognostic marker in hypertrophic cardiomyopathy (HCM) and may be progressive. The precise mechanisms underlying fibrosis progression are...

Detaylı Bibliyografya
Asıl Yazarlar:	Raman, B, Ariga, R, Spartera, M, Sivalokanathan, S, Chan, K, Dass, S, Petersen, SE, Daniels, MJ, Francis, J, Smillie, R, Lewandowski, AJ, Ohuma, EO, Rodgers, C, Kramer, CM, Mahmod, M, Watkins, H, Neubauer, S
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	Oxford University Press 2018

Benzer Materyaller

Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
Yazar:: Masliza Mahmod, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
Yazar:: Raman, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
Yazar:: Ariga, R, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
Yazar:: Ariga, R, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
Yazar:: Hudsmith, L, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.
Yazar:: Petersen, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
Yazar:: Raman, B, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
Yazar:: Ariga, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy
Yazar:: Sanjay Sivalokanathan
Baskı/Yayın Bilgisi: (2022-01-01)

Discrepancy between pathological progression and clinical stability in a young patient with hypertrophic cardiomyopathy
Yazar:: Raman, B, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
Yazar:: Betty Raman, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis
Yazar:: Ashkir, Z, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
Yazar:: Suttie, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
Yazar:: Dass, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
Yazar:: Lyon, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study
Yazar:: Siontis, KC, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

ACUTE DERANGEMENT OF CARDIAC ENERGY METABOLISM AND OXYGENATION DURING STRESS IN HYPERTROPHIC CARDIOMYOPATHY-A POTENTIAL MECHANISM FOR SUDDEN CARDIAC DEATH
Yazar:: Dass, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity
Yazar:: Harper, AR, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca2+ flux caused by thin filament hypertrophic cardiomyopathy mutations
Yazar:: Sparrow, AJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
Yazar:: Dass, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
Yazar:: Kramer, CM, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Further refining risk in hypertrophic cardiomyopathy with late gadolinium enhancement by CMR
Yazar:: Kramer, C, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Sudden death in hypertrophic cardiomyopathy.
Yazar:: Watkins, H
Baskı/Yayın Bilgisi: (2000)

Response to letter regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
Yazar:: Dass, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy
Yazar:: Waring, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Risk stratification in hypertrophic cardiomyopathy based on QRS and T wave morphological biomarkers identifies three phenotypic subgroups
Yazar:: Lyon, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Myocardial dysfunction in hypertrophic cardiomyopathy.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Exercise acutely exacerbates derangement of cardiac energy metabolism in hypertrophic cardiomyopathy, a 31 phosphorus magnetic resonance study at 3 Telsa
Yazar:: Dass, S, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.
Yazar:: Karamitsos, T, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Left and right ventricular tissue velocities are reduced in hypertrophic cardiomyopathy but not in athlete's heart
Yazar:: Petersen, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Assessment of myocardial fibre structure in hypertrophic cardiomyopathy with magnetic resonance diffusion tensor imaging
Yazar:: Ariga, R
Baskı/Yayın Bilgisi: (2018)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric MRI
Yazar:: Petersen, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
Yazar:: Dass Sairia, ve diğerleri
Baskı/Yayın Bilgisi: (2012-02-01)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
Yazar:: Petersen, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Extraction of morphological QRS-based biomarkers in hypertrophic cardiomyopathy for risk stratification using L1 regularized logistic regression
Yazar:: Lyon, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
Yazar:: Aung, N, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
Yazar:: Neubauer, S, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
Yazar:: Dass, S
Baskı/Yayın Bilgisi: (2012)

Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects
Yazar:: Fitri Fareez Ramli, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)